Federal Judge Upholds Legality of Drug Transparency Law Requiring Manufacturers to Report Drug Price Increases to Department of Insurance

By Hannah Ohman On January 4, 2021, the United States District Court for the Eastern District of California filed an order upholding the legality of a 2017 California drug price transparency law in Pharmaceutical Research & Manufacturers of America (“PhRMA”) Continue reading